ImmunoTargets and Therapy

ISSN: 2253-1556

Editor-in-Chief: Dr Michael R Shurin

An international, peer-reviewed open access journal focusing on the immunological basis of diseases, potential targets for immune based therapy and treatment protocols employed to improve patient management. Basic immunology and physiology of the immune system in health, and disease will be also covered.

This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).

Special offer: Original research and review papers submitted by December 31, 2017 using the promotional code PRJ16 will receive a fee waiver off the publication processing fee.   

Indexed online:

• Emerging Sources Citation Index (ESCI), from 2016
• PubMed and PubMed Central (Immunotargets Ther)
• Embase, from 2015 (Correct as at December 8, 2016)
• Directory of Open Access Journals (DOAJ)
• OAIster: The Open Access initiative